We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CPhI Expert Calls for Radical Change to the Pharma Manufacturing Process

News   Sep 18, 2015

 
CPhI Expert Calls for Radical Change to the Pharma Manufacturing Process
 
 
Advertisement
 

RELATED ARTICLES

PerkinElmer to Acquire Horizon Discovery

News

The companies have reached an agreement whereby PerkinElmer will acquire Horizon for approximately $383 million with the deal expected to close in the first quarter of 2021.

READ MORE

Cobra Biologicals Plasmids To Begin Phase I Clinical Trial for COVID-19 Vaccine

News

Cobra Biologics (Cobra) and Scancell Holdings plc (Scancell), announced that they have entered into a collaboration for Cobra to manufacture Scancell’s COVID-19 vaccine. Scancell’s DNA vaccine will target the SARS-CoV-2 nucleocapsid (N) protein plus the key receptor binding domain of the spike (S) protein to generate both T cell responses and virus neutralising antibodies against the SARS-CoV-2 virus.

READ MORE

Collaborations Aim To Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE